Maven Clinic, the industry-leading virtual clinic for women’s and family health, is officially returning to its origins. The company announced today the launch of its new direct-to-consumer platform, marking a strategic shift to provide women across the U.S. with direct access to its integrated, longitudinal virtual care model.
Since its founding in 2014, Maven has become a powerhouse in the enterprise space, partnering with over 2,300 employers and health plans to support more than 28 million covered lives. While the company built its reputation scaling these B2B relationships, today’s announcement represents a homecoming to the consumer-first approach that defined its early years.
Founder and CEO Kate Ryder noted that the current healthcare landscape for women is paradoxically more crowded yet more fragmented than ever. “Women have more ways to manage their health today than ever before — and less coherence than ever before,” she said. “We spent a decade inside the healthcare system building the clinical foundation to close the many gaps in care women and families face. Today we’re bringing that model directly to women everywhere — trusted providers, integrated care, and a clear point of view on what women need.”
The new consumer platform offers three core areas of focus. First, members gain access to Maven’s proprietary network of over 30 specialties, including OB-GYNs, mental health professionals, nutritionists, and doulas, all within a single integrated platform. Unlike transactional, one-off appointments, Maven emphasizes a “full story” approach where care plans evolve alongside the user, ensuring that fertility questions, pregnancy planning, and hormone care are connected through a unified clinical history.
Second, Maven is entering the GLP-1 space with a focus on metabolic health that explicitly accounts for reproductive history, PCOS, and life stages like perimenopause. This program includes medical oversight, nutrition guidance, and muscle-preservation strategies, moving beyond simple BMI-focused prescribing. Finally, the platform features comprehensive hormone care, designed to support transitions like perimenopause and menopause by offering evaluation and ongoing management for symptoms that are frequently dismissed or undertreated, such as brain fog, sleep disruption, and mood shifts.
The move to a direct-to-consumer model is not intended to displace Maven’s enterprise success but rather to complement it. The company plans to make these consumer offerings available to employers and health plans starting in 2027, allowing for a hybrid model that extends coverage across all life stages.
For the women’s health sector, Maven’s expansion signals a continued shift away from single-use, “point solution” applications toward multi-touch, holistic ecosystems. By leveraging its existing clinical infrastructure and decade-long data insights, Maven is betting that the future of women’s health lies in long-term, accountable relationships rather than one-time transactions. The beta waitlist for the new platform is open as of today.
